MicroRNA-144 mediates metabolic shift in ovarian cancer cells by directly targeting Glut1

Tumour Biol. 2016 May;37(5):6855-60. doi: 10.1007/s13277-015-4558-9. Epub 2015 Dec 11.

Abstract

Warburg effect is characterized by an increased utilization of glucose via glycolysis in cancer cells, even when enough oxygen is present to properly respire. Recent studies demonstrate that deregulation of microRNAs contributes to the Warburg effect. In the present study, we show that miR-144 is downregulated while glucose transporter 1 (Glut1) is upregulated in ovarian cancers. In vitro studies further showed that miR-144 inhibits Glut1 expression through targeting its 3'-untranslated region. As a result, cells overexpressing miR-144 exhibited a metabolic shift, including enhanced glucose uptake and lactate production. The altered glucose metabolism induced by miR-144 also leads to a rapid growth of ovarian cancer cells. Taken together, our results indicate that miR-144 may serve as a molecular switch to regulate glycolysis in ovarian cancer by targeting the expression of Glut1.

Keywords: Glut1; MicroRNA-144; Ovarian cancer; Warburg effect.

Publication types

  • Retracted Publication

MeSH terms

  • 3' Untranslated Regions
  • Animals
  • Binding Sites
  • Cell Line, Tumor
  • Cell Proliferation
  • Disease Models, Animal
  • Down-Regulation
  • Energy Metabolism
  • Female
  • Gene Expression Regulation, Neoplastic*
  • Glucose / metabolism
  • Glucose Transporter Type 1 / genetics*
  • Glycolysis
  • Heterografts
  • Humans
  • Male
  • Mice
  • MicroRNAs / genetics*
  • Ovarian Neoplasms / genetics*
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / pathology
  • RNA Interference*
  • Tumor Burden

Substances

  • 3' Untranslated Regions
  • Glucose Transporter Type 1
  • MIRN144 microRNA, human
  • MicroRNAs
  • Glucose